Papers
2
Total Citations
26
H-Index
2
About
Ang Gao is a leading radiation oncologist whose research focuses on advancing stereotactic body radiation therapy (SBRT) for breast cancer, particularly through innovative partial breast irradiation techniques. Her major contributions include pioneering dose-escalation trials that establish safe and effective protocols for single-fraction and five-fraction stereotactic partial breast irradiation (S-PBI) in early-stage breast cancer patients. Her 2021 multi-institutional Phase 1 dose-escalation trial, cited 23 times, demonstrated the feasibility of single-fraction S-PBI using a robotic stereotactic system, offering a paradigm shift toward ultra-hypofractionated, non-invasive treatment. This work builds on her earlier 2016 Phase 1 trial exploring five-fraction regimens, which laid the groundwork for reducing treatment duration while maintaining tumor control and minimizing toxicity. Gao’s research directly impacts clinical practice by enabling more convenient, cost-effective breast cancer care with fewer hospital visits. Her studies are widely referenced in the radiation oncology community, underscoring her role in refining SBRT applications for breast cancer. Through these contributions, she continues to shape the future of precision radiotherapy, improving outcomes and quality of life for patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2